A Study to Evaluate the Long-term Safety and Efficacy of ASP015K in Subjects Previously Enrolled in a Phase 2 ASP015K Rheumatoid Arthritis Study

NCT01711814 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

611

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: peficitinib

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]